BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hua Y, Wu J, Wu H, Su C, Li X, Ao Q, Zeng Q, Zhu X, Zhang X. Exposure to hydroxyapatite nanoparticles enhances Toll-like receptor 4 signal transduction and overcomes endotoxin tolerance in vitro and in vivo. Acta Biomater 2021;135:650-62. [PMID: 34525415 DOI: 10.1016/j.actbio.2021.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zeng Q, Wang R, Hua Y, Wu H, Chen X, Xiao Y, Ao Q, Zhu X, Zhang X. Hydroxyapatite nanoparticles drive the potency of Toll-like receptor 9 agonist for amplified innate and adaptive immune response. Nano Res . [DOI: 10.1007/s12274-022-4683-x] [Reference Citation Analysis]
2 Shang L, Shao J, Ge S. Immunomodulatory Properties: The Accelerant of Hydroxyapatite-Based Materials for Bone Regeneration. Tissue Eng Part C Methods 2022. [PMID: 35196904 DOI: 10.1089/ten.TEC.2022.00111112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chen X, Zhang Y, Fu Y. The Critical Role of Toll-like Receptor-mediated Signaling in Cancer Immunotherapy. Medicine in Drug Discovery 2022. [DOI: 10.1016/j.medidd.2022.100122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]